Abstract:Objective To report one-center experience on diagnosis and treatment of cytomegalovirus (CMV) pneumonia in recipients after living-related donor kidney transplantation (LDKT).Methods The clinical and follow-up data of 168 recipients after LDKT from April 2005 to September 2014 were analyzed retrospectively.We analyzed the general information,clinical manifestation,treatment and outcomes of 34 recipients who were diagnosed as CMV pneumonia.Of the 34 patients,26 were male and 8 were female.The average age were 32.0 years old.Thirty-four patients developed CMV pneumonia between 12 to 402 days with an average of (91.7 ±60.8) days post-transplant.It was (6.4 ±3.7) d(range 1-14 d) from the onset of illness to seeking medical intervention.All cases presented with fever,18 cases with dyspnea,11 cases with cough and 6 cases with myalgia or fatigue.The highest temperature was (38.8 ± 0.5) ℃ (range 38.0-40.0℃).Leukocyte count was (10.5 ± 4.4) × 109/L,elevated in 18 cases,normal in 14 cases,reduced in 2 cases.Quantitative polymerase chain reaction(PCR) assay for CMV DNA was (9.3-15.8) × 103 copies/ml for active CMV infection.Chest X ray or CT of all cases demonstrated patchy shadow or interstitial pneumonia.The etiological examination showed that 12 cases were complicated with other microorganism,including 8 cases with Pneumocystis carinii,3 cases with Streptococcus A,3 cases with Neisseria,3 cases with candida albicans,2 cases with klebsiella pneumoniae,Staphylococcus aureus,enterococcus faecium,Pseudomonas aeruginosa varied 1 case.Results In antiviral therapy,patients were treated by introvenous ganciclovir 5 mg/kg every 12 h for 14-21d and then 5 mg/kg every day.Glucocorticoid treatment included intravenous methylprednisolone 200 mg/kg for 3-5 d,then gradually reduced to 160 mg/kg for 3-5 d,120 mg/kg for 3 d,80 mg/kg for 3 d,40 mg/kg for 3-5 d,until to the original oral dose.Early application of broad-spectrum antibiotics was to prevent bacterial infection,and routine application of compound sulfamethoxazole to prevent Pneumocystis carinii pneumonia.Treatment options were adjusted according to periodic bacteria and fungal culture in blood,urine or sputum,and effective anti bacterial,viral or fungal treatment was selected.After administration of antiviral therapy,methylprednisolone,treatment for other microorganism,as well as adjusted immunosuppressive drugs,30 cases were cured.The total course of the pneumonia lasted for (28.5 ± 9.4) days on average.However,4 patients complicated with other microorganism died of severe pneumonia and acute respiratory distress syndrome(ARDS).Conclusion CMV infection was a common complication of living-related donor kidney transplantation.CMV infection often complicated with other microbial infections,and became one of the causes of death after renal transplantation.Early diagnosis,early antiviral therapy combined with effective anti bacterial,fungal treatment would improve the survival of kidney transplant recipients.

Cytomegalovirus Infection Is Associated with Development of Chronic Lung Allograft Dysfunction

Association between cytomegalovirus viremia and long-term outcomes in lung transplant recipients

Innate and adaptive effector immune drivers of cytomegalovirus disease in lung transplantation: a double-edged sword

Cytomegalovirus and chronic allograft rejection in liver transplantation.

Progress on the association between human gene polymorphisms and cytomegalovirus infection after transplantation

Association of Cytomegalovirus Infection with Human Leukocyte Antigen Genotypes in Recipients after Allogeneic Liver Transplantation.

Infection prophylaxis and management of viral infection

Opportunistic Infections Post-Lung Transplantation: Viral, Fungal, and Mycobacterial

CMV Primary Infection Is Associated With Donor-Specific T Cell Hyporesponsiveness and Fewer Late Acute Rejections After Liver Transplantation.

The Impact of Pretransplant Cytomegalovirus Infection on Acute Renal Allograft Rejection

NKG2C Natural Killer Cells in Bronchoalveolar Lavage Are Associated With Cytomegalovirus Viremia and Poor Outcomes in Lung Allograft Recipients

Cytomegalovirus Pneumonia after Living-Related Donor Kidney Transplantation: the Experiences of One Single Center Within 10 Years

The Association Between Cytomegalovirus Infection and Kidney Damage in the Liver Transplant Setting

[Clinical Predictors of Cytomegalovirus Infection after Liver Transplantation].

Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data

Immunomodulatory Therapy of Cytomegalovirus Pneumonia after Liver Transplantation.

Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy

Characteristics of cytomegalovirus infection following liver transplantation

Cytomegalovirus Retinitis in the Modern Era of Solid Organ Transplantation

QuantiFERON CMV Test and CMV Serostatus in Lung Transplant: Stratification Risk for Infection, Chronic and Acute Allograft Rejection

Specific Immunity to Cytomegalovirus in Pediatric Cardiac Transplantation